25 May 2018
Import Restrictions on Synthetic Opioid Continued
The U.S. Drug Enforcement Administration has extended for one year the temporary placement into schedule I of the Controlled Substances Act the synthetic opioid N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-Nphenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide (beta-hydroxythiofentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers.
As a result, effective through 12 May 2019 beta-hydroxythiofentanyl will remain subject to the regulatory controls and administrative, civil and criminal sanctions applicable to the manufacture, distribution, reverse distribution, importation, exportation, research, conduct of instructional activities and chemical analysis and possession of schedule I controlled substances. The DEA has also issued a proposed rule that would permanently place this product into schedule I, with comments due by 14 June.